T lymphocytes from patients with acute EBV-induced infectious mononucleosis rapidly die by apoptosis in vitro. Because human and viral IL-10 are likely to be induced during acute EBV infection and display a variety of functions on human T cells, we examined IL-10 effects on infectious mononucleosis T cell death. After 12 h of incubation in medium alone, only 35.6 (+8.2%) of the originally seeded infectious mononucleosis T cells were viable. Addition of human IL-10 (100 U/ml) to T cell cultures significantly improved recovery of viable cells (71.3+6.2%, P = 0.0156). Viral IL-10 had comparable effects to human IL-10 in this system. Protection from death by human and viral IL-10 (100 U/ml) was dose dependent and continued over a 6-d culture period. The human IL-10 effect was neutralized by the anti-human IL-10 mAb 19F1. Morphology and analysis of DNA after separation on agarose gels showed that IL-10 inhibits loss of cell volume, chromatin condensation, and DNA fragmentation, characteristics of death by apoptosis. As assessed by [3Hjthymidine incorporation, the T cells were not induced to proliferate by IL-10 above the level exhibited when first removed from blood. T cells protected from death by IL-10 proliferated to IL-2 and spontaneously killed sensitive targets as effectively as medium-precultured T cells. Thus, IL-10 promotes the survival of infectious mononucleosis T cells otherwise destined to die by apoptosis and may be critical for the establishment of immunologic memory after resolution of the illness. (J. Clin. Invest. 1994. 94:251-260.)
Introduction
Acute infectious mononucleosis (Mono),' a manifestation of primary infection with EBV, is characterized by virus replication in the oropharynx, latent virus infection in a proportion of the B cells, and reactive T cell lymphocytosis (1) (2) (3) . The T death in vivo, we know that lymphadenopathy and T cell lymphocytosis are generally transient during EBV-induced Mono ( 11) . Upon resolution of the illness, the lymphadenopathy disappears, and the absolute number of circulating T cells, as well as the relative proportion of CD4+ and CD8 + cells, returns to normal ( 12) . This points to a rapid clearance of activated T cells from the lymphoid organs and from the circulation, features that characterize death by apoptosis in vivo (13) . However, a balance must exist between death and survival of immune reactive T cells because immunologic memory is established after resolution of acute EBV-induced Mono (14, 15) .
The presence of EBV replication in the oropharynx during Mono suggests that the late viral gene BCRF-I is expressed in the productively infected cells and that its protein product, viral IL-10 (vIL-10), is secreted by these cells (11, 16) . There is also evidence to suggest that viral and human IL-10 (hIL-10) are expressed in EBV-infected B cells (17) . Thus, the oropharyngeal epithelium and lymphoid tissues should be sites of IL-10 production during EBV-induced Mono. The structurally homologous viral and human IL-10 share a number of biological properties, including inhibition of IFN-y production (16) , suppression of T cell proliferation in response to antigen and mitogen ( 18) , inhibition of cytokine production by activated monocytes ( 19) , and stimulation of B cell growth and immunoglobulin production (20, 21) . This has raised the possibility that EBV might have captured, during evolution, the IL-10 gene for its own advantage (22) .
The present experiments were undertaken to evaluate the role of IL-10 on T cell immunity during acute EBV-induced Mono and to specifically address the possibility that this cytokine is an important regulator of T cell survival.
Methods
Study population. The study population consisted of 23 patients diagnosed as having acute EBV-induced Mono at Georgetown University Student Health Center. The diagnosis of EBV-induced Mono was based upon the presence of fever, pharyngitis, lymphadenopathy, lymphocytosis with atypical lymphocytes, and the presence of heterophile antibodies as determined by a positive monospot test (Monosticon Dri-Dot; Organon Teknika, Durham, NC). The patients ranged from 18 to 23 yr; 14 were male, and 9 were female. No patient had received steroids before the study.
Reagents, antibodies, and cytokines. The murine mAb anti-CD25 (anti-Tac) was purified from hybridoma ascites by using protein ASepharose (a gift of Dr. T. Waldmann, National Institutes of Health, Bethesda, MD; reference 23). A purified murine anti-hIL-2 neutralizing mAb was purchased from Genzyme Corp. (Cambridge, MA); a concentration of 4 pHg/ml was found to neutralize 50% of the proliferation of activated peripheral blood T cells induced by 10 U recombinant hIL-2 (Cetus Corp., Emeryville, CA). TCR61, an mAb against the T cell y6 receptor, was obtained as FITC-conjugated from T Cell Sciences, Inc. (Cambridge, MA). The mAbs anti-CD3 (anti-Leu-4), anti-CD4 (antiLeu-3a), anti-CD5 (anti-Leu-l), anti-CD8 (anti-Leu-2a), anti-CD20 (anti-Leu-16), anti-CD25 (anti-hIL-2 receptor), anti-CD38 (antiLeu-17), anti-CD71 (anti-transferrin receptor), anti-TCRa/3 (anti-T cell af receptor), and anti-HLA-DR were purchased as FITC-conjugates from Becton Dickinson Immunocytometry Systems (Mountain View, CA). The neutralizing anti-hIL-10 mAb was a gift of Dr. J. Abrams (DNAX Research Institute Palo Alto, CA; reference 19).
hIL-10 was purified from culture supernatants of Chinese hamster ovary cells stably transfected with the hIL-10 gene and contained 107 U/mg. Murine IL-10 (mIL-10) was baculovirus derived and contained 14,000 U/ml. Both hIL-10 and mIL-10 were a kind gift of Dr. K.
Moore (DNAX Research Institute; references 16 and 24) . A unit of IL-10 is defined as the amount inducing half-maximal stimulation of MC/9 mast cells, as described (25) . Recombinant hIL-2 was from Cetus Corp.
Cells and culture conditions. T lymphocytes were obtained from PBMC by density centrifugation after rosetting with 2-aminoethylisothiouronium-treated sheep red blood cells (26 Cell viability and cell morphology. Cell viability was determined by light and fluorescent microscopy after cell staining with acridine orange (4 I.g/ml; Sigma Chemical Co.) and trypan blue (0.02%; Sigma Chemical Co.). As described (27, 28) , viable cells were easily identified as trypan blue-negative cells displaying bright green nuclear chromatin fluorescence with organized structure. Cell morphology was evaluated by light microscopy examination of May-Grunwald Giemsa-stained cells subjected to cytocentrifugation. A cell was considered morphologically apoptotic when it displayed loss of cell volume, chromatin condensation along the nuclear membrane with intensely basophilic staining, and/or nuclear fragmentation into spherical structures containing condensed chromatin, still surrounded by membrane (29) .
DNA electrophoresis. DNA fragmentation analysis was performed essentially as described (30 Immunofluorescence analysis. Immunofluorescence staining of cell surface markers was performed as described (34) . After the cells were stained with the appropriate FITC-conjugated mAb, the cells were analyzed using a FACScanb cytometer (Becton Dickinson Immunocytometry Systems) equipped with a 488 nm air-cooled argon laser and linked to a computer (Hewlett-Packard Co., Palo Alto, CA). Detection of FITC was carried out with detectors set at 530 nm. 20 ,000 cells were analyzed.
Data were acquired using Consort 30 and analyzed using Lysis I software (Becton Dickinson Immunocytometry Systems).
Statistical analysis. Group differences were analyzed for significance by Wilcoxon signed-rank test or Mann-Whitney U test.
Results
IL-JO protects Mono T cells from spontaneous death by apoptosis. It has been reported previously that Mono T cells rapidly die when incubated in vitro (9, 10) . As shown in a representative experiment (Fig. 1 A) , only 40.8 and 33.8% of the originally seeded Mono peripheral blood T cells were still alive after 12-and 24-h incubations, respectively. A cell was considered viable when it both excluded trypan blue on light microscopy and exhibited bright green nuclear fluorescence when stained with acridine orange, as described (27, 28) . This contrasts with normal peripheral blood T cells that generally are > 90% viable after 24 h of incubation under identical conditions (not shown). We examined whether hIL-10 had an effect on Mono T cell survival in vitro. As shown (Fig. 1 A) 54.2% of the originally seeded Mono T cells were still alive after 12 and 24 h of incubation, respectively ( Fig. 1 A) .
In seven separate experiments with T cells from different patients with acute EBV-induced Mono, only 35.6±8.2% of the originally cultured T cells were viable after incubation in medium alone for 12 h, but 71.3±6.2% were viable when incubated under identical culture conditions plus 100 U/ml hIL-10 (P = 0.0156, by Wilcoxon signed-rank test) (Fig. 1 B) .
The viability-promoting effect of hIL-10 was reversed by the neutralizing effect of 19F1, an anti-hIL-10 mAb, but not by anti-Tac (CD25), an anti-hIL-2 receptor mAb (Table I , Experiments I and 2). Also, when added alone to Mono T cells (Table I , Experiment 1), 19F1 mAb alone had little or no effect on T cell viability, suggesting that death and survival of Mono T cells in this system are not influenced by endogenously produced during incubation. In addition, the finding that antiTac mAb had no effect on the viability-promoting effect of L-10 suggests that endogenously produced hIL-2 does not have a substantial effect on T cell viability in this system. To test this further, a neutralizing mAb to hIL-2 was also used. As shown (Table I , Experiment 3), anti-hIL-2 mAb had little or no effect on the viability-promoting effect of In this system, increased T cell viability induced by hIL-IO is dose dependent. Although some effect was observed at 4 U/ml, a much greater induction of cell viability by hIL-10 occurred at 100 U/ml (Fig. 2) .
vIL-lO also promoted cell viability in Mono T cells. When added at 100 U/ml, the magnitude of the effect was comparable with that induced by hIL-10 at the same concentration. As expected, hIL-2 also promoted T cell viability (Fig. 2) .
Although microscopic examination permits us to distinguish live from dead cells, its accuracy may be limited by the subjective nature of the evaluations. To confirm the viability-promoting effect of IL-10 by a more objective method, we have used the property of metabolically active cells to enzymatically convert the yellow tetrazolium salt MTT into a dark blue formazan salt. The amount of MTT formazan produced, measured as absorbance at 570 nm, is proportional to the number of viable cells, regardless of the presence of nonviable cells, and is also related, in part, to the degree of cell activation (31) . As shown in Fig. 3 , hIL-10 dose-dependently enhanced the conversion of MTT to MTT formazan by Mono T cells. This stimulatory effect of hIL-10 was specific in that it was neutralized by the anti-hIL-10 mAb 19F1 added at 0.05 or 2 pg/ml. vIL-10 (100 U/ml) also stimulated MTT conversion into MTT formazan by Mono T cells, but mIL-10 (100 U/ml) did not (Fig. 3) . These findings are consistent with the observation that hIL-lO and vIL-10 promote the viability of Mono T cells in culture. suggest that hIL-10 increases T cell viability in this system by preventing cell death rather than by stimulating cell growth.
IL-JO inhibits apoptosis in Mono T cells. Previous studies have demonstrated that T cells from patients with acute EBVinduced Mono rapidly die by apoptosis as demonstrated both
by cell morphology and DNA fragmentation (9, 10) . We examined the effects of IL-1O on T cell death as assessed both by morphology and DNA fragmentation.
As shown in Fig. 4 , whereas > 90% of the Mono T cells just purified from peripheral blood appeared morphologically viable on cytocentrifuged smears (A), only a small proportion of these T cells appeared viable after 12 h of incubation in medium alone (B). A number of these cells show loss of cell volume, nuclear condensation, and fragmentation, characteristic of apoptosis, while other cells appeared as cell ghosts. Addition of hIL-10 ( Fig. 4 C) or vIL-lO (Fig. 4 D) during the 12-h incubation visibly enhanced the number of morphologically viable cells and reduced the number of apoptotic and ghostic cells.
As shown in Fig. 5 , DNA electrophoresis of Mono T cells incubated for 12 h in medium alone resulted in a ladder pattern, characteristic of DNA fragmentation in oligonucleotide bands (lane 6). In contrast, DNA electrophoresis of the same Mono T cells incubated under otherwise identical culture conditions except for the addition of 100 U/ml hIL-10 (Fig. 5, lane 5) or vIL-10 (Fig. 5, lane 2) showed a reduced level of DNA fragmentation. A similarly reduced degree of DNA fragmentation was noted in T cells incubated with 100 U/ml hIL-2 (Fig.  5, lane 1) . No evidence of fragmentation was seen in DNA from fresh Mono T cells (Fig. 5, lane 7) . Together, these findings confirm the rapid occurrence of death by apoptosis in Mono T cells ex vivo and further demonstrate that IL-10 inhibits this process.
Phenotype andfunction ofMono T cells. Expression of the T cell marker CD3 and of the histocompatibility class II antigen HLA-DR (Fig. 6) 
with or without hIL-10 were tested for their ability to kill these two target cell populations. As shown in a representative experiment (Fig. 7) , Mono T cells precultured with hIL-10 were more effective than cells precultured in medium alone at killing each of the targets. The apparent greater level of killing by hIL-10-precultured T cells might be a consequence, in part, of increased survival of the activated, more cytotoxic T cells induced by IL-10.
Proliferation in response to hIL-2 was also measured. Equal numbers of viable cells were obtained from cultures of Mono T cells treated for 12 h with or without hIL-IO. As shown in Table III , hIL-10-precultured T cells proliferated in response to hIL-2 at varying concentrations at least as well as mediumprecultured T cells. These functional studies suggest that cells spared from death by IL-10 can still proliferate and exert cytotoxic activity.
Discussion
In this study we have found that hIL-10 and vIL-10 promote the survival of Mono T cells that are otherwise destined to die rapidly by apoptosis. Over a 6-d period of incubation, cultures of Mono T cells contained significantly more viable cells when exogenous IL-10 was initially added to the culture medium. In addition, IL-10 treatment was associated with a reduction in the number of T cells with condensed and fragmented nuclei and in the degree of DNA fragmentation in T cells.
This survival effect of IL-10 was not due to T cell growth stimulation by IL-10, as monitored by [3H]thymidine incorporation. Rather, IL-10 appeared to delay the death in vitro of T cells activated in vivo. When added together with 1L-2 and IL-4, or at least 11L-2, IL-10 can stimulate T cell growth (36, 37) . However, IL-2 was not required for IL-10 to promote T cell survival in the present system, because neutralization of 11L-2 or of the 1L-2 receptor alpha chain failed to inhibit the survival effect of IL-10. It is possible that the effect of IL-10 on T cell survival is indirect and mediated through IFN-y. Unlike IL-10, IFN-y was reported to both promote T cell death by apoptosis (38) and to be required during thymocyte death by apoptosis (39) . By inhibiting IFN-y production by Mono T cells, IL-10 might cause increased T cell survival.
It is important to note that Mono T cells spared from death by IL-10 appeared similar to viable, medium-treated cells in the expression of a number of T cell-specific and activationrelated markers, including CD3, CD4, CD8, CD25, HLA-DR, and transferrin receptor. Furthermore, the IL-10-protected T cells continued to be functional, as demonstrated by their ability to effectively kill targets sensitive to cytotoxicity by Mono T cells and to subsequently proliferate in response to IL-2. Thus, IL-10 acts to ensure the persistence of functional T cell clones that would otherwise spontaneously die by apoptosis.
We have demonstrated recently that hIL-10 promotes the survival of IL-2-dependent T cells that have been starved of IL-2 and are destined to die by apoptosis (34) . The data presented here extend these earlier observations and further demonstrate that the viability-promoting effect of hIL-10 is shared by vIL-10 and includes T (9, 10) . A balance must exist, however, between death and survival of EBV-immune T cells because after acute infection a highly effective memory population is retained, exhibiting much of the properties of T cells during the acute disease (14, 15) .
The mechanism for the selective and regulated death by apoptosis of unwanted T cells after resolution of the acute disease is not understood. Previous studies in other systems have raised the possibility that survival of many cells is dependent upon extracellular survival signals (44, 46) . In the absence of such signals, the cells would be normally programmed to die. It is possible that EBV-infected cells play a critical role in controlling the survival of T cells. By producing IL-10 ( 16, 17, 21 ) and a variety of other factors that can regulate T cell growth and survival, including IL-12 (47), IL-6 (48), lymphotoxin (49) , and TNF-a (50), B cells and epithelial cells infected with EBV may regulate initial growth and survival of immune T cells. Once EBV replication in the oropharynx diminishes or subsides, and the number of circulating EBV-infected B cells is reduced, the availability of growth and survival factors for T cells may also be reduced, and most of the immune T cells may subsequently die.
The molecular basis for programmed cell death is also not understood. The mammalian gene bc1-2 has been shown to suppress programmed cell death in many cells (51 EBV is a successful pathogen that has managed to infect most adults worldwide and has done so by periodically replicating in the oropharynx and establishing latency in B cells (53) . Successful infiltration of EBV in the human species has occurred in the face of effective and complex T cell regulation (54) . Because EBV has probably acquired the BCRF-1 gene during evolution, it is important to ask whether vIL-10 expression may have contributed to virus survival. It was proposed that by inhibiting IFN-y production and T cell growth IL-10 suppresses T cell immunity and promotes B cell immortalization by EBV (16) . IFN-y is known to inhibit B cell immortalization by EBV in vitro (55) . Infection of normal mice with recombi- (58) . However, IL-10 promotes B cell growth, including growth of EBV-immortalized B cells (59) , and increases B cell survival by inhibiting cell death (60) . Thus, the effects of IL-10 on EBV infection appear to be more complex than had been anticipated. Very little is known about the mechanisms for the establishment and persistence of long-lived memory T cells directed at EBV. The principal growth and survival factor for T cells, IL-2, is not widely available for T cells in vivo, and various mechanisms are believed to operate in vivo to guarantee compartmentalization of IL-2, thus avoiding systemic effects (49) . In the absence of IL-2, T cell survival may depend upon other factors, including IL-10.
